Journal of Applied Physiology Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 98: 180-185, 2005. First published September 17, 2004; doi:10.1152/japplphysiol.00913.2004
8750-7587/05 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
98/1/180    most recent
00913.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (15)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burki, N. K.
Right arrow Articles by Lee, L.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burki, N. K.
Right arrow Articles by Lee, L.-Y.

Intravenous adenosine and dyspnea in humans

Nausherwan K. Burki,1 Wheeler J. Dale,2 and Lu-Yuan Lee3

1Division of Pulmonary Medicine, Department of Medicine, University of Connecticut Health Center, Farmington, Connecticut; 2Department of Medicine, University of Kentucky Medical Center, and 3Department of Physiology, University of Kentucky, Lexington, Kentucky

Submitted 20 August 2004 ; accepted in final form 15 September 2004

Intravenous adenosine for the treatment of supraventricular tachycardia is reported to cause bronchospasm and dyspnea and to increase ventilation in humans, but these effects have not been systematically studied. We therefore compared the effects of 10 mg of intravenous adenosine with placebo in 21 normal subjects under normoxic conditions and evaluated the temporal sequence of the effects of adenosine on ventilation, dyspnea, and heart rate. The study was repeated in 11 of these subjects during hyperoxia. In all subjects, adenosine resulted in the development of dyspnea, assessed by handgrip dynamometry, without any significant change (P > 0.1) in lung resistance as measured by the interrupter technique. There were significant increases (P < 0.05) in ventilation and heart rate in response to adenosine. The dyspneic response occurred slightly before the ventilatory or heart rate responses in every subject, but the timing of the dyspneic, ventilatory, and heart rate responses was not significantly different when the group data were analyzed (18.9 ± 5.8, 20.3 ± 5.5, and 19.7 ± 4.5 s, respectively). During hyperoxia, adenosine resulted in similar effects, with no significant differences in the magnitude of the ventilatory response; however, compared with the normoxic state, the intensity of the dyspneic response was significantly (P < 0.05) reduced, whereas the heart rate response increased significantly (P < 0.05). These data indicate that intravenous adenosine-induced dyspnea is not associated with bronchospasm in normal subjects. The time latency of the response indicates that the dyspnea is probably not a consequence of peripheral chemoreceptor or brain stem respiratory center stimulation, suggesting that it is most likely secondary to stimulation of receptors in the lungs, most likely vagal C fibers.

asthma; pulmonary vagal C fibers; ventilation; chemoreceptors



Address for reprint requests and other correspondence: N. K. Burki, Div. of Pulmonary Medicine, Dept. of Medicine, Univ. of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030-1225 (E-mail: nburki{at}uchc.edu)




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y.-L. Chou, M. D. Scarupa, N. Mori, and B. J. Canning
Differential effects of airway afferent nerve subtypes on cough and respiration in anesthetized guinea pigs
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1572 - R1584.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. M. Reynolds, R. Docherty, J. Robbins, D. Spina, and C. P. Page
Adenosine induces a cholinergic tracheal reflex contraction in guinea pigs in vivo via an adenosine A1 receptor-dependent mechanism
J Appl Physiol, July 1, 2008; 105(1): 187 - 196.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. R. DeSesa, R. P. Vaughan, M. J. Lanosa, K. G. Fontaine, and J. B. Morris
Sulfur-Containing Malodorant Vapors Enhance Responsiveness to the Sensory Irritant Capsaicin
Toxicol. Sci., July 1, 2008; 104(1): 198 - 209.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
R. P. Vaughan, M. T. Szewczyk Jr, M. J. Lanosa, C. R. DeSesa, G. Gianutsos, and J. B. Morris
Adenosine Sensory Transduction Pathways Contribute to Activation of the Sensory Irritation Response to Inspired Irritant Vapors
Toxicol. Sci., October 1, 2006; 93(2): 411 - 421.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. Chuaychoo, M.-G. Lee, M. Kollarik, R. Pullmann Jr, and B. J. Undem
Evidence for both adenosine A1 and A2A receptors activating single vagal sensory C-fibres in guinea pig lungs
J. Physiol., September 1, 2006; 575(2): 481 - 490.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
B. J. Undem and M. Kollarik
The Role of Vagal Afferent Nerves in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2005; 2(4): 355 - 360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.